Novartis (NVS) CEO Vas Narasimhan “thinks” the company has an agreement with the U.S. to protect it from tariffs, believing its $23B investment in manufacturing announced last year would act as a barrier against levies, Tasmin Lockwood of CNBC reports, citing comments made by Narasimhan. This comes after U.S. President Donald Trump said he plans to impose 10% tariffs on the U.K., Denmark, Norway, Sweden, France, Germany, the Netherlands, and Finland by February 1.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- These European Stocks Could Be in the Firing Line in Trump’s Greenland Tariff War
- Novartis price target raised to CHF 125 from CHF 120 at Deutsche Bank
- Novartis receives FDA Breakthrough Therapy designation for ianalumab
- Trump Trade: White House releases details on ‘Great Healthcare Plan’
- Drugmakers concerned about legal risk with FDA review program, Reuters reports